Pharma and Biotech
By Sean Farrell
Date: Thursday 15 Jul 2021
(Sharecast News) - Nuformix's annual loss widened as revenue fell and the pharmaceutical company spent to development its treatments.
By Sean Farrell
Date: Wednesday 10 Feb 2021
(Sharecast News) - Chris Blackwell has quit as Nuformix's chairman a year after taking the job at the drug development company.
By Josh White
Date: Thursday 18 Jul 2019
(Sharecast News) - Nuformix reported total revenue of £0.61m in its final results on Thursday, rising from £0.02m in the prior year, with the company swinging to a gross profit of £0.07m, from a loss of £0.19m.
| Currency | UK Pounds |
| Share Price | 0.31p |
| Change Today | 0.005p |
| % Change | -1.59 % |
| 52 Week High | 0.32p |
| 52 Week Low | 0.048p |
| Volume | 23,261,271 |
| Shares Issued | 1,995.71m |
| Market Cap | £6.19m |
| RiskGrade | 322 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:29 | 300,000 @ 0.31p |
| 16:26 | 46,640 @ 0.32p |
| 16:25 | 400,000 @ 0.30p |
| 16:14 | 81,559 @ 0.31p |
| 16:08 | 300,000 @ 0.30p |
You are here: research